Evidence map›Paper›PMID 23666178›Full record

ArticleNature neuroscience2013

Overexpression of Down syndrome cell adhesion molecule impairs precise synaptic targeting.

Vedrana Cvetkovska, Alexa D Hibbert, Farida Emran, Brian E Chen

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. PNAS nexus · 2023
    Article
  10. Article
  11. Article
  12. Dscam1 overexpression impairs the function of the gut nervous system in Drosophila.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Article
  13. Structure of cell-cell adhesion mediated by the Down syndrome cell adhesion molecule.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. I-KCKT allows dissection-free RNA profiling of adultDevelopment (Cambridge, England) · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vedrana CvetkovskaCentre for Research in Neuroscience, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
Alexa D Hibbert
Farida Emran
Brian E Chen
McGill University Health Centre · CA

Funding

CIHR 103295-1CIHR 119610-1
6 · The paper itself

Abstract

Fragile X syndrome is caused by the loss of Fragile X mental retardation protein (FMRP), an RNA-binding protein that suppresses protein translation. We found that FMRP binds to Down syndrome cell adhesion molecule (Dscam) RNA, a molecule that is involved in neural development and has been implicated in Down syndrome. Elevated Dscam protein levels in FMRP null Drosophila and in flies with three copies of the Dscam gene both produced specific and similar synaptic targeting errors in a hard-wired neural circuit, which impaired the flies' sensory perception. Reducing Dscam levels in FMRP null flies reduced synaptic targeting errors and rescued behavioral responses. Our results indicate that excess Dscam protein may be a common molecular mechanism underlying altered neural wiring in intellectual disabilities such as Fragile X and Down syndromes.

Indexed as

Gene Expression RegulationAnimalsBehavior, AnimalBrainCell Adhesion MoleculesDown SyndromeDrosophila melanogasterDrosophila ProteinsFragile X Messenger Ribonucleoprotein 1NeuronsSynapsesCell Adhesion MoleculesDrosophila ProteinsDscam1 protein, DrosophilaFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID23666178
PMCPMC3954815
OpenAlexW2006269312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.